22L-15616-02072

2 vaccinations 16 coded responses 24 check-ins 16 free-text entries 9 call cases

Sex: Female
Age at first dose: 36-40
ZIP prefix: 300 / GA
Registered: 2020-12-26

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2020-12-26
Registered in v-safe
2020-12-26
Dose 1 — Pfizer-BioNTech
2020-12-26
Survey response — day 0, dose 1
MedDRA: Dizziness, Flushing — Feeling: Good · Get care from a doctor or other healthcare professional · Emergency room or emergency department visit

Free text: Flushing, dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-26
Report sent to call center — day 0, dose 1
Get care from a doctor or other healthcare professional

1 call case(s)
2020-12-27
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Good · Site: Pain · Headache

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-28
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2020-12-30
Survey response — days 1–6 daily, dose 1
MedDRA: Dizziness — Feeling: Good · Headache

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-31
Survey response — days 1–6 daily, dose 1
MedDRA: Migraine — Feeling: Fair · Headache · Be unable to do your normal daily activities

Free text: Migraine

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2020-12-31
Report sent to call center — days 1–6 daily, dose 1
Be unable to do your normal daily activities

1 call case(s)
2021-01-01
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-02
Health check-in — day 7, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-08
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-01-08
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-01-09
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-15
Dose 2 — Pfizer-BioNTech
2021-01-15
Survey response — day 0, dose 2
MedDRA: Flushing, Hypoaesthesia, Tachycardia — Feeling: Good · Site: Pain

Free text: Flushing, tachycardia, facial numbness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-16
Survey response — days 1–6 daily, dose 2
MedDRA: Injection site pain — Feeling: Good · Site: Pain · Joint pains, Muscle or body aches

Free text: Pain at injection site

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Site: Pain · Chills, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-17
Report sent to call center — days 1–6 daily, dose 2
Be unable to do your normal daily activities

1 call case(s)
2021-01-18
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-19
Survey response — days 1–6 daily, dose 2
MedDRA: Dizziness — Feeling: Fair · Fatigue or tiredness

Free text: Dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-01-20
Health check-in — days 1–6 daily, dose 2
Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work

Adult check-in
2021-01-21
Health check-in — days 1–6 daily, dose 2
Feeling: Good · None

Adult check-in
2021-01-22
Health check-in — day 7, dose 2
Feeling: Fair · Fever · Headache, Muscle or body aches, Fatigue or tiredness

Adult check-in
2021-01-29
Survey response — day 14, dose 2
MedDRA: Fatigue, Feeling abnormal, Headache, Migraine, Paraesthesia, Sinus pain — Feeling: Fair · Be unable to do your normal daily activities

Free text: Facial tingling, brain fog, headaches/migraine, severe fatigue, sinus pain

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Survey response — day 21, dose 2
MedDRA: Dizziness, Flushing, Presyncope, Tachycardia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Flushing, tachycardia, dizziness, presyncope

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-05
Report sent to call center — day 21, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-12
Survey response — day 28, dose 2
MedDRA: Chest pain, Dizziness, Flushing, Presyncope, Tachycardia — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Flushing, tachycardia, near syncope, chest pain, dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-12
Report sent to call center — day 28, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-19
Survey response — day 35, dose 2
MedDRA: Dizziness, Flushing, Hypersensitivity, Paraesthesia, Swelling face, Tachycardia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: On prednisone for delayed allergic reaction. Episodes of swollen flushed face, tachycardia, dizziness, tingling in arms and legs

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-19
Report sent to call center — day 35, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-02-28
Survey response — day 42, dose 2
MedDRA: Dizziness, Exercise tolerance decreased, Flushing, Paraesthesia, Tachycardia — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit

Free text: Continued tachycardia, poor exercise tolerance, paresthesias, flushing, dizziness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-28
Report sent to call center — day 42, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-04-16
Survey response — 3 months, dose 2
MedDRA: Medical counselling, Small fibre neuropathy — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: I have been diagnosed with small fiber neuropathy which started after the vaccine. I am back on steroids and rheumatologist thinks I have drug induced lupus

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-04-16
Report sent to call center — 3 months, dose 2
Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional

1 call case(s)
2021-06-08
Call successful
Reported to VAERS voluntarily prior to GDIT contact
2021-07-16
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-15
Survey response — 12 months, dose 2
MedDRA: Biochemical pregnancy, Polyarthritis — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit

Free text: Polyarthritis, chemical pregnancy

MedDRA releases: 2024-11 · check-in free text available
2022-01-15
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Get care from a doctor or other healthcare professional

Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-01-17
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2020-12-26	Pfizer-BioNTech
2	2021-01-15	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2020-12-26	Successful 2021-01-08	Reported to VAERS voluntarily prior to GDIT contact
2020-12-31	Successful 2021-01-08	Reported to VAERS voluntarily prior to GDIT contact
2021-01-17	priority 2/3
2021-02-05	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-02-12	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-02-19	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-02-28	Successful	Reported to VAERS voluntarily prior to GDIT contact
2021-04-16	Successful 2021-06-08	Reported to VAERS voluntarily prior to GDIT contact
2022-01-15	Unsuccessful

Free text

Release 1 — day 0, dose 1

2020-12-26

Systemic reaction (other): Flushing, dizziness

Release 1 — days 1–6 daily, dose 1

2020-12-27

Systemic reaction (other): Dizziness

2020-12-30

Systemic reaction (other): Dizziness

2020-12-31

Systemic reaction (other): Migraine

Release 2 — day 0, dose 2

2021-01-15

Systemic reaction (other): Flushing, tachycardia, facial numbness

Release 2 — days 1–6 daily, dose 2

2021-01-16

Systemic reaction (other): Pain at injection site

2021-01-17

Systemic reaction (other): Dizziness

2021-01-18

Systemic reaction (other): Dizziness

2021-01-19

Systemic reaction (other): Dizziness

Release 3 — day 14, dose 2

2021-01-29

Symptoms: Facial tingling, brain fog, headaches/migraine, severe fatigue, sinus pain

Release 3 — day 21, dose 2

2021-02-05

Symptoms: Flushing, tachycardia, dizziness, presyncope

Release 4 — day 28, dose 2

2021-02-12

Symptoms: Flushing, tachycardia, near syncope, chest pain, dizziness

Release 4 — day 35, dose 2

2021-02-19

Symptoms: On prednisone for delayed allergic reaction. Episodes of swollen flushed face, tachycardia, dizziness, tingling in arms and legs

Release 4 — day 42, dose 2

2021-02-28

Symptoms: Continued tachycardia, poor exercise tolerance, paresthesias, flushing, dizziness

Release 7 — 3 months, dose 2

2021-04-16

Symptoms: I have been diagnosed with small fiber neuropathy which started after the vaccine. I am back on steroids and rheumatologist thinks I have drug induced lupus

Release 10 — 12 months, dose 2

2022-01-15

Symptoms: Polyarthritis, chemical pregnancy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Biochemical pregnancy	·	·	✓
SD	Chest pain	✓	✓	✓
SD	Dizziness	✓	✓	✓
SD	Exercise tolerance decreased	✓	✓	✓
SD	Fatigue	✓	✓	✓
SD	Feeling abnormal	✓	✓	✓
SD	Flushing	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hypersensitivity	✓	✓	✓
SD	Medical counselling	✓	✓	✓
SD	Migraine	✓	✓	✓
SD	Paraesthesia	✓	✓	✓
SD	Polyarthritis	·	·	✓
SD	Presyncope	✓	✓	✓
SD	Sinus pain	✓	✓	✓
SD	Small fibre neuropathy	✓	✓	✓
SD	Swelling face	✓	✓	✓
SD	Tachycardia	✓	✓	✓
SRO	Dizziness	✓	✓	✓
SRO	Flushing	✓	✓	✓
SRO	Hypoaesthesia	✓	✓	✓
SRO	Injection site pain	✓	✓	✓
SRO	Migraine	✓	✓	✓
SRO	Tachycardia	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release